Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Department of Medical Epidemiology.
ViLabs.
J Epidemiol. 2024 Nov 5;34(11):515-525. doi: 10.2188/jea.JE20230358. Epub 2024 May 25.
BACKGROUND: Despite the high frequency of tinnitus and its impact on wellbeing, little is known about its economic burden, and, to our knowledge, no data are available on out-of-pocket (OOP) expenses. METHODS: In 2022, a survey was conducted on OOP costs of tinnitus. We enrolled 679 participants with slight, moderate, and severe tinnitus in Italy, United Kingdom, Netherlands, Germany, and Spain. We estimated annual OOP expenses for tinnitus-related healthcare visits, treatments, medications, and alternative medicine practices. Prevalence of tinnitus in the general population, obtained from a representative survey we conducted in Europe in 2017-2018, was used to generalize costs for people with any tinnitus at the national level. RESULTS: OOP expenses were 368€ (95% confidence intervals [CI], 78€-690€), 728€ (95% CI, 316€-1,288€), and 1,492€ (95% CI, 760€-2,688€) for slight, moderate, and severe tinnitus, respectively, with annual expenditure of 565€ for people with any tinnitus: 209€ for healthcare visits; 93€ for treatments; 16€ for drugs; 64€ for hearing supporting systems; and 183€ for acupuncture, homeopathy, and osteopathy. Individuals with slight, moderate, and severe tinnitus expressed a willingness to invest 1.6, 4.3, and 7.0 times their monthly income, respectively, to achieve complete relief from tinnitus. CONCLUSION: This study offers for the first time insights into the OOP expenses incurred by individuals with tinnitus. OOP expenses exhibited substantial variations based on severity status, accounting for more than 17 billion € in the countries considered. In terms of financial burden, these findings align tinnitus to the recognized leading disabilities, including back pain and migraine.
背景:尽管耳鸣的发病率很高,且对幸福感有影响,但人们对其经济负担知之甚少,据我们所知,尚无关于自费(OOP)支出的数据。
方法:2022 年,我们对耳鸣的 OOP 成本进行了调查。我们在意大利、英国、荷兰、德国和西班牙招募了 679 名轻度、中度和重度耳鸣患者。我们估计了与耳鸣相关的医疗就诊、治疗、药物和替代医学实践的年度 OOP 支出。我们使用了我们在 2017-2018 年在欧洲进行的一项代表性调查中获得的一般人群中耳鸣的患病率,将其推广到全国任何程度耳鸣患者的成本。
结果:轻度、中度和重度耳鸣患者的 OOP 支出分别为 368 欧元(95%置信区间[CI],78-690 欧元)、728 欧元(95% CI,316-1,288 欧元)和 1,492 欧元(95% CI,760-2,688 欧元),任何程度耳鸣患者的年支出为 565 欧元:209 欧元用于医疗就诊;93 欧元用于治疗;16 欧元用于药物;64 欧元用于听力支持系统;183 欧元用于针灸、顺势疗法和整骨疗法。轻度、中度和重度耳鸣患者分别表示愿意投资其月收入的 1.6、4.3 和 7.0 倍,以完全缓解耳鸣。
结论:这项研究首次提供了有关耳鸣患者自费支出的见解。根据严重程度,OOP 支出存在很大差异,在考虑的国家中超过 170 亿欧元。就经济负担而言,这些发现将耳鸣与公认的主要残疾(包括背痛和偏头痛)相提并论。
J Epidemiol. 2024-11-5
Int J Mol Sci. 2025-6-17
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025-3
J Epidemiol. 2025-8-5
J Assoc Res Otolaryngol. 2024-10
J Clin Med. 2023-4-24
Laryngorhinootologie. 2023-5
Cochrane Database Syst Rev. 2022-11-16
Int J Environ Res Public Health. 2022-8-22
JAMA Neurol. 2022-9-1
Front Neurosci. 2022-2-15
Lancet Reg Health Eur. 2021-11-4